Methylphenidate Hydrochloride Tablet, Extended Release
Product Images NDC 72162-2395

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Methylphenidate Hydrochloride (NDC 72162-2395). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Lbl721622395)

Label (Lbl721622395)
This text provides information on a tablet containing 27 mg of Methylphenidate Hydrochloride in a controlled-release formulation. It includes storage instructions, dosage details, and advises keeping the medication away from children. Also, it suggests a pharmacist dispense the medication guide to each patient along with the package insert. The tablets are mentioned to be extended-release following USP guidelines for controlled room temperature storage.*
FDA Label Image

Chemical Structure (Methylphenidate Hydrochloride Extended Release Tab 1)

FDA Label Image

Figure 1 (Methylphenidate Hydrochloride Extended Release Tab 2)

Figure 1 (Methylphenidate Hydrochloride Extended Release Tab 2)
This text provides information on the dosing schedule for Methylphenidate HCI in different concentrations (18 mg once daily and 5 mg three times daily) and displays the mean plasma Methylphenidate concentrations over a 28-hour period.*
FDA Label Image

Figure 2 (Methylphenidate Hydrochloride Extended Release Tab 3)

Figure 2 (Methylphenidate Hydrochloride Extended Release Tab 3)
This text appears to be a description of a study comparing the effects of Methylphenidate HC (given once daily) and a placebo. The study is referred to as Study 1 Sumly 2 Stutyd. Unfortunately, the full information about the study or its results could not be derived from the provided text.*
FDA Label Image

Figure 3 (Methylphenidate Hydrochloride Extended Release Tab 4)

Figure 3 (Methylphenidate Hydrochloride Extended Release Tab 4)
This is a table showing data from two different groups across different time points, with information related to "Combined Attention Subscales" and "Ao Hours Post Initial Dose". The values in the table represent mean scores with standard error of mean for each group and time point.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.